147 related articles for article (PubMed ID: 38141134)
1. Analysis of GATA3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a mature yolk sac tumor phenotype may underlie sarcomatoid transformation.
Ricci C; Ambrosi F; Grillini A; Massari F; Fiorentino M; Colecchia M; Ulbright TM; Acosta AM
Virchows Arch; 2024 Apr; 484(4):709-713. PubMed ID: 38141134
[TBL] [Abstract][Full Text] [Related]
2. FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type.
Ricci C; Ambrosi F; Franceschini T; Giunchi F; Di Filippo G; Franchini E; Massari F; Mollica V; Tateo V; Bianchi FM; Colecchia M; Acosta AM; Fiorentino M
Histopathology; 2023 Sep; 83(3):465-476. PubMed ID: 37317674
[TBL] [Abstract][Full Text] [Related]
3. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns.
Zynger DL; McCallum JC; Luan C; Chou PM; Yang XJ
Histopathology; 2010 May; 56(6):750-7. PubMed ID: 20546340
[TBL] [Abstract][Full Text] [Related]
4. Many postchemotherapy sarcomatous tumors in patients with testicular germ cell tumors are sarcomatoid yolk sac tumors: a study of 33 cases.
Howitt BE; Magers MJ; Rice KR; Cole CD; Ulbright TM
Am J Surg Pathol; 2015 Feb; 39(2):251-9. PubMed ID: 25229769
[TBL] [Abstract][Full Text] [Related]
5. The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
Wruck W; Bremmer F; Kotthoff M; Fichtner A; Skowron MA; Schönberger S; Calaminus G; Vokuhl C; Pfister D; Heidenreich A; Albers P; Adjaye J; Nettersheim D
J Cell Mol Med; 2021 Feb; 25(3):1394-1405. PubMed ID: 33448076
[TBL] [Abstract][Full Text] [Related]
6. Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors.
Chahoud J; Zhang M; Pisters LL; Lin SC; Lin SH; Tu SM
Clin Genitourin Cancer; 2018 Oct; 16(5):325-327. PubMed ID: 29807831
[No Abstract] [Full Text] [Related]
7. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent In Situ Hybridization Analysis for 12p Alterations in Sarcomatoid Yolk Sac Tumors.
Idrees MT; Ulbright TM; Epstein JI
Am J Surg Pathol; 2019 Nov; 43(11):1566-1573. PubMed ID: 31478941
[TBL] [Abstract][Full Text] [Related]
9. HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors.
Gallo A; Fankhauser C; Hermanns T; Beyer J; Christiansen A; Moch H; Bode PK
Mod Pathol; 2020 Nov; 33(11):2354-2360. PubMed ID: 32561848
[TBL] [Abstract][Full Text] [Related]
10. "Somatic-type" malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin.
Magers MJ; Kao CS; Cole CD; Rice KR; Foster RS; Einhorn LH; Ulbright TM
Am J Surg Pathol; 2014 Oct; 38(10):1396-409. PubMed ID: 24921638
[TBL] [Abstract][Full Text] [Related]
11. Oncofetal protein glypican-3 in testicular germ-cell tumor.
Ota S; Hishinuma M; Yamauchi N; Goto A; Morikawa T; Fujimura T; Kitamura T; Kodama T; Aburatani H; Fukayama M
Virchows Arch; 2006 Sep; 449(3):308-14. PubMed ID: 16896894
[TBL] [Abstract][Full Text] [Related]
12. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
13. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors.
Rougemont AL; Tille JC
Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846
[TBL] [Abstract][Full Text] [Related]
14. Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach.
Fichtner A; Richter A; Filmar S; Kircher S; Rosenwald A; Küffer S; Nettersheim D; Oing C; Marx A; Ströbel P; Bremmer F
Histopathology; 2022 Jan; 80(2):381-396. PubMed ID: 34506648
[TBL] [Abstract][Full Text] [Related]
15. Glypican 3: a novel marker in testicular germ cell tumors.
Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
[TBL] [Abstract][Full Text] [Related]
16. [Non-seminomatous germ cell tumours].
Bremmer F; Behnes CL; Schweyer S
Pathologe; 2014 May; 35(3):238-44. PubMed ID: 24819978
[TBL] [Abstract][Full Text] [Related]
17. High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
Shojaei H; Hong H; Redline RW
Mod Pathol; 2016 Oct; 29(10):1278-88. PubMed ID: 27443515
[TBL] [Abstract][Full Text] [Related]
18. Pitfalls in the interpretation of specimens from patients with testicular tumours, with an emphasis on variant morphologies.
Ulbright TM
Pathology; 2018 Jan; 50(1):88-99. PubMed ID: 29129333
[TBL] [Abstract][Full Text] [Related]
19. The utility of CDX2, GATA3, and DOG1 in the diagnosis of testicular neoplasms: an immunohistochemical study of 109 cases.
Osman H; Cheng L; Ulbright TM; Idrees MT
Hum Pathol; 2016 Feb; 48():18-24. PubMed ID: 26772394
[TBL] [Abstract][Full Text] [Related]
20. Sarcomatoid Yolk Sac Tumor Harbors Somatic Mutations That Are Otherwise Rare in Testicular Germ Cell Tumors.
Acosta AM; Al-Obaidy KI; Sholl LM; Dickson BC; Lindeman NI; Hirsch MS; Collins K; Fletcher CD; Idrees MT
Am J Surg Pathol; 2022 May; 46(5):701-712. PubMed ID: 35034041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
